AXIL Signs Agreement with Beretta Hellas LTD to Distribute AXIL Hearing Protection and Enhancement Products in Greece
LOS ANGELES, April 15, 2024 (GLOBE NEWSWIRE) — AXIL Brands, Inc. (“AXIL,” “we,” “us,” “our,” or the “Company”) (NYSE American: […]
Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange
SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its […]
Marathon Digital Holdings Appoints Manoj Narender Madnani as Managing Director for EMEA Expansion
Fort Lauderdale, FL, April 15, 2024 (GLOBE NEWSWIRE) — Marathon Digital Holdings, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), one of the […]
Microbot Medical Shares Status Following Recent Geopolitical Events
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company Believes […]
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]
iPower to Participate in the Water Tower Research Fireside Chat Series on April 18
RANCHO CUCAMONGA, Calif., April 15, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and […]
LiveOne (Nasdaq: LVO) Subsidiary Slacker Radio Hits All Time High Country Music Usage, Helping to Increase Revenue 300% and Driving a Remarkable 800% Increase in Share of Female Country Artists Across Radio Programming
– Management Guides Slacker Radio to $85M and $20M Adjusted EBITA for FY2025; a 4X Revenue Growth and Increase of […]
Longeveron’s CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer’s Association International Conference (AAIC)
MIAMI, April 15, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today […]
PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement
Fiscal 2024 3Q Revenue of $65.3 million, an 11% increase compared to last year including PetCareRx results.AutoShip & Save and […]
KULR Technology Group Announces Appointment of Donna H. Grier to its Board of Directors
Former DuPont Executive Brings Decades of Private and Public Market Experience to Company’s Board SAN DIEGO, April 15, 2024 (GLOBE […]
